Cardiovascular risks post-COVID-19 vaccination: Key findings

FHS
October 3, 2024
10:29 am

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

J&J appoints Shawn Millerick to lead vision care unit in the Americas

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Shawn Millerick, Johnson & Johnson’s president of

December 2, 2024

Roche wins first-line approval for PI3K inhibitor combo in breast cancer

Roche’s Itovebi is a PI3K inhibitor that prevents the activation of the PI3K-mediated signalling pathway, resulting in the inhibition of the growth and survival of

October 11, 2024

BioNTech nabs up to $90M for mpox vaccine as it begins PhI/II trial behind Moderna’s lead

Building on its infectious disease work in Covid-19, malaria and tuberculosis, BioNTech is now rolling out a Phase I/II test of a jab to protect

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.